craiyon logo

Four scientists in lab coats examine holographic screens displaying data on "MindBio Therapeutics Corp" and "Psychedelic Microdosing Therapy," with images of pills and human anatomy.

Four scientists in lab coats examine holographic screens displaying data on "MindBio Therapeutics Corp" and "Psychedelic Microdosing Therapy," with images of pills and human anatomy.

🧠 Psychedelic Microdosing Play to Watch MindBio Therapeutics Corp is a clinical stage biotech developing take home microdosing psychedelic therapies for mental health conditions like depression, anxiety, PTSD, and distress in cancer patients. Their lead candidate MB22001 is advancing through Phase 2 clinical development, targeting scalable, regulated psychedelic treatment protocols. Thesis Snapshot: • Positioned in the fast growing psychedelic therapeutics sector • Focus on take home micro dosing mode💊 • Acquisition of AI health monitoring tech to support digital therapeutics integration • 🔬Advancing late stage clinical trials • Massive unmet need in global mental health markets Early positioning in a potentially transformative sector. Mehr sehen